FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2191141911> ?p ?o ?g. }

• W2191141911 abstract "Diffuse large B-cell lymphoma (DLBCL) is a clinically heterogeneous lymphoid malignancy and the most common subtype of non-Hodgkin's lymphoma in adults, with one of the highest mortality rates in most developed areas of the world. More than half of DLBLC patients can be cured with standard R-CHOP regimens, however approximately 30 to 40 % of patients will develop relapsed/refractory disease that remains a major cause of morbidity and mortality due to the limited therapeutic options.Recent advances in gene expression profiling have led to the identification of at least three distinct molecular subtypes of DLBCL: a germinal center B cell-like subtype, an activated B cell-like subtype, and a primary mediastinal B-cell lymphoma subtype. Moreover, recent findings have not only increased our understanding of the molecular basis of chemotherapy resistance but have also helped identify molecular subsets of DLBCL and rational targets for drug interventions that may allow for subtype/subset-specific molecularly targeted precision medicine and personalized combinations to both prevent and treat relapsed/refractory DLBCL. Novel agents such as lenalidomide, ibrutinib, bortezomib, CC-122, epratuzumab or pidilizumab used as single-agent or in combination with (rituximab-based) chemotherapy have already demonstrated promising activity in patients with relapsed/refractory DLBCL. Several novel potential drug targets have been recently identified such as the BET bromodomain protein (BRD)-4, phosphoribosyl-pyrophosphate synthetase (PRPS)-2, macrodomain-containing mono-ADP-ribosyltransferase (ARTD)-9 (also known as PARP9), deltex-3-like E3 ubiquitin ligase (DTX3L) (also known as BBAP), NF-kappaB inducing kinase (NIK) and transforming growth factor beta receptor (TGFβR).This review highlights the new insights into the molecular basis of relapsed/refractory DLBCL and summarizes the most promising drug targets and experimental treatments for relapsed/refractory DLBCL, including the use of novel agents such as lenalidomide, ibrutinib, bortezomib, pidilizumab, epratuzumab, brentuximab-vedotin or CAR T cells, dual inhibitors, as well as mechanism-based combinatorial experimental therapies. We also provide a comprehensive and updated list of current drugs, drug targets and preclinical and clinical experimental studies in DLBCL. A special focus is given on STAT1, ARTD9, DTX3L and ARTD8 (also known as PARP14) as novel potential drug targets in distinct molecular subsets of DLBCL." @default.
• W2191141911 created "2016-06-24" @default.
• W2191141911 creator A5013250439 @default.
• W2191141911 creator A5035462617 @default.
• W2191141911 creator A5042219528 @default.
• W2191141911 date "2015-12-01" @default.
• W2191141911 modified "2023-10-16" @default.
• W2191141911 title "Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review" @default.
• W2191141911 cites W1020989877 @default.
• W2191141911 cites W1021645331 @default.
• W2191141911 cites W1115219378 @default.
• W2191141911 cites W1135493307 @default.
• W2191141911 cites W117290765 @default.
• W2191141911 cites W130153342 @default.
• W2191141911 cites W1482937398 @default.
• W2191141911 cites W1488181101 @default.
• W2191141911 cites W1500781157 @default.
• W2191141911 cites W1514488017 @default.
• W2191141911 cites W1535776410 @default.
• W2191141911 cites W1548735291 @default.
• W2191141911 cites W1565539350 @default.
• W2191141911 cites W1584131524 @default.
• W2191141911 cites W1600317768 @default.
• W2191141911 cites W1628369270 @default.
• W2191141911 cites W1648663357 @default.
• W2191141911 cites W1706303017 @default.
• W2191141911 cites W1712157683 @default.
• W2191141911 cites W1728255343 @default.
• W2191141911 cites W1755870104 @default.
• W2191141911 cites W1774902545 @default.
• W2191141911 cites W1794063461 @default.
• W2191141911 cites W1816898406 @default.
• W2191141911 cites W1825629489 @default.
• W2191141911 cites W1839388921 @default.
• W2191141911 cites W1863976964 @default.
• W2191141911 cites W1866424446 @default.
• W2191141911 cites W1881635332 @default.
• W2191141911 cites W1884715737 @default.
• W2191141911 cites W1893048570 @default.
• W2191141911 cites W1901965502 @default.
• W2191141911 cites W1913007537 @default.
• W2191141911 cites W1931280990 @default.
• W2191141911 cites W1933096416 @default.
• W2191141911 cites W1935050347 @default.
• W2191141911 cites W1951423934 @default.
• W2191141911 cites W1954043953 @default.
• W2191141911 cites W1960875028 @default.
• W2191141911 cites W1963522404 @default.
• W2191141911 cites W1964194155 @default.
• W2191141911 cites W1964840824 @default.
• W2191141911 cites W1965134361 @default.
• W2191141911 cites W1965323869 @default.
• W2191141911 cites W1965570423 @default.
• W2191141911 cites W1965657711 @default.
• W2191141911 cites W1965807814 @default.
• W2191141911 cites W1966062502 @default.
• W2191141911 cites W1966542058 @default.
• W2191141911 cites W1967054089 @default.
• W2191141911 cites W1967304777 @default.
• W2191141911 cites W1967531846 @default.
• W2191141911 cites W1968325836 @default.
• W2191141911 cites W1970400561 @default.
• W2191141911 cites W1970739365 @default.
• W2191141911 cites W1971659434 @default.
• W2191141911 cites W1972426790 @default.
• W2191141911 cites W1973160387 @default.
• W2191141911 cites W1973454407 @default.
• W2191141911 cites W1973544030 @default.
• W2191141911 cites W1974431455 @default.
• W2191141911 cites W1974654770 @default.
• W2191141911 cites W1974714084 @default.
• W2191141911 cites W1974815914 @default.
• W2191141911 cites W1974816429 @default.
• W2191141911 cites W1975913714 @default.
• W2191141911 cites W1976140288 @default.
• W2191141911 cites W1976158386 @default.
• W2191141911 cites W1976174817 @default.
• W2191141911 cites W1976402300 @default.
• W2191141911 cites W1976524637 @default.
• W2191141911 cites W1976564639 @default.
• W2191141911 cites W1976773284 @default.
• W2191141911 cites W1977261138 @default.
• W2191141911 cites W1977314095 @default.
• W2191141911 cites W1977434752 @default.
• W2191141911 cites W1977635491 @default.
• W2191141911 cites W1977824829 @default.
• W2191141911 cites W1978932947 @default.
• W2191141911 cites W1979274352 @default.
• W2191141911 cites W1979433258 @default.
• W2191141911 cites W1979816280 @default.
• W2191141911 cites W1980190478 @default.
• W2191141911 cites W1980920506 @default.
• W2191141911 cites W1981957956 @default.
• W2191141911 cites W1982448638 @default.
• W2191141911 cites W1982494540 @default.
• W2191141911 cites W1982581888 @default.
• W2191141911 cites W1982834279 @default.
• W2191141911 cites W1982905137 @default.
• W2191141911 cites W1983056774 @default.
• W2191141911 cites W1984198270 @default.

• next